INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Lipid effects of endocrine medications.

Show full item record

Bookmark or cite this item: http://hdl.handle.net/10027/7576

Files in this item

File Description Format
PDF Mazzone - Table 1-1.pdf (78KB) Table 1 PDF
PDF Mazzone - edited2.pdf (129KB) Main article PDF
Title: Lipid effects of endocrine medications.
Author(s): Mihailescu, Dan V.; Vora, Avni; Mazzone, Theodore
Subject(s): lipids cardiovascular
Abstract: Various alterations of lipid homeostasis have a significant role in the pathophysiology of the artherosclerotic process. The effects of usual lipid-lowering agents such as statins, fibrates, or niacin are well known, but other endocrine therapeutic agents could also affect the blood levels of various lipoproteins and, in turn, influence atheroma formation. In this review, we attempt to summarize the effect of several hormonal and non-hormonal endocrine agents on lipid metabolism, including insulin, thyroid hormone, sex hormones, glucocorticoids, growth hormone, and several anti-diabetic agents.
Issue Date: 2011-02
Publisher: Springer Verlag
Citation Info: Mihailescu, D. V., Vora, A., & Mazzone, T. 2010. Lipid Effects of Endocrine Medications. Current Atherosclerosis Reports . DOI: 10.1007/s11883-010-0146-z
Type: Article
Description: The original publication is available at www.springerlink.com; DOI: 10.1007/s11883-010-0146-z
URI: http://hdl.handle.net/10027/7576
ISSN: 1534-6242
Sponsor: TM has received a grant from Takeda for research support as well as an honorarium from Abbott for consulting work. DVM and IV report no potential conflicts of interest relevant to this article.
Date Available in INDIGO: 2011-05-05
 

This item appears in the following Collection(s)

Show full item record

Statistics

Country Code Views
United States of America 79
China 32
United Kingdom 13
Indonesia 1
Netherlands 1

Browse

My Account

Information

Access Key